Eris Lifesciences Ltd - 540596 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Eris Lifesciences has made available the recording of its earnings conference call for the Q4 and FY26 audited financial results. The call was held on May 20, 2026, and the recording is accessible on the company's website, providing investors with details on its financial performance.
May 20 2026 19:05:00
Eris Life Q4 Results: Stock gains 12% as Domestic Branded Formulations leads growth
Eris Lifesciences reported a 4% year-on-year decrease in Q4 FY24 net profit to ₹100 crore and a marginal dip in revenue to ₹447 crore. Despite the Q4 performance, the company has set ambitious targets, aiming for ₹2,500 crore in revenue for FY25 and a 35% margin by FY27, supported by the upcoming launch of Semaglutide pens and recent acquisitions in insulin and dermatology segments.
May 20 2026 15:05:00
Eris Lifesciences Ltd - 540596 - Corporate Action-Board approves Dividend
Eris Lifesciences declared an interim dividend of ₹7.21 per equity share for FY26-27. The record date for eligible shareholders is May 29, 2026, with payment due by June 19, 2026.
May 20 2026 14:05:00
Eris Lifesciences Ltd - 540596 - Board Meeting Outcome for Outcome Of Board Meeting
Eris Lifesciences board approved audited cons. financial results for FY26, reporting a revenue of ₹3,129.42 cr and net profit of ₹647.51 cr. The company also declared an interim dividend of ₹7.21 per equity share for FY26-27, with payment scheduled by June 19, 2026.
May 20 2026 14:05:00
Eris Lifesciences Ltd - 540596 - Board Meeting Intimation for Consideration Of Financial Results And Interim Dividend
Eris Lifesciences board is scheduled to meet on May 20, 2026. The agenda includes approval of Q4 FY26 financial results and consideration of an interim dividend for FY27.
May 15 2026 14:05:00
Eris Lifesciences Ltd - 540596 - Announcement under Regulation 30 (LODR)-Credit Rating
India Ratings and Research affirmed Eris Lifesciences's Long-term Issuer Rating and bank facilities at 'IND AA' with a Stable outlook. This affirmation reflects sustained healthy operating performance and strong competitive position.
May 08 2026 17:05:00
Read More